牛皮关节炎管理的全球指南:比较分析
Shikha Singla1, Parjanya Bhatt2, Enrique Roberto Soriano
1From the Medical College of Wisconsin, Milwaukee, WI.
概括
全球牛皮关节炎 (PsA) 准则建议使用治疗到目标的策略. 然而,生物和向疾病修饰性抗风湿药物 (DMARDs),肠炎和牙炎管理的治疗顺序存在显著差异.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 临床指南开发 临床指南开发
背景情况:
- 牛皮关节炎 (PsA) 是一种复杂的,免疫媒介的炎症性疾病,涉及多个系统.
- 由于PsA的异构性质,对PsA的治疗决策具有挑战性.
- 对全球指导方针的比较分析对于完善PsA管理策略至关重要.
研究的目的:
- 为了比较分析最新的全球牛皮关节炎 (PsA) 管理指南.
- 突出不同方法治疗各种PSA领域的差异.
- 为未来的PsA治疗策略提供信息和指导.
主要方法:
- 对主要国际PSA管理指南进行系统审查.
- 包括主要风湿病学协会2018年至2024年的指导方针.
- 对不同PSA领域的治疗建议进行比较分析.
主要成果:
- 在活跃的PsA中为治疗到点策略的一致建议.
- 对于生物和向疾病修饰性抗风湿药物 (DMARDs) 的治疗顺序的分歧.
- 在治疗肠炎和牙炎方面观察到的变化;并发症是控制疾病的关键.
结论:
- 全球指南提出了多样化的管理策略,用于牛皮关节炎 (PsA).
- 未来的建议可能包括新的治疗目标.
- 优化PsA护理需要解决并发症,并根据特定疾病领域量身定制治疗方法.
相关概念视频
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Rheumatic Heart Disease III: Medical Management
36
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
36
Atherosclerosis III: Management
41
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
41
Inflammatory Bowel Disease IV: Pharmacological Management
200
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
200
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K


